When Jennifer Mitchell, manager of the Cath Lab and Interventional Radiology at SSM Health St. Joseph Hospital – St. Charles in Missouri, postponed routine screening mammograms in late 2021 due to a busy work schedule, she joined millions of healthcare professionals prioritizing patient care over personal health. However, a birthday screening in January 2022 led to a stage 1 triple-negative breast cancer diagnosis, completely shifting her perspective from provider to patient.
In Plain English: The Clinical Takeaway
- Triple-Negative Breast Cancer: An aggressive subtype of breast cancer that lacks estrogen receptors, progesterone receptors, and human epidermal growth factor receptor 2 (HER2) expression, meaning it does not respond to hormone therapies or HER2-targeted drugs.
- Dense Breast Tissue: Fibrous and glandular tissue that can obscure abnormalities on a mammogram, frequently requiring supplemental imaging modalities such as ultrasound or biopsy for definitive evaluation.
- Adjuvant Multimodal Therapy: A sequential treatment regimen combining chemotherapy, surgical resection, and reconstructive procedures to minimize recurrence risk in early-stage malignancies.
Delaying Mammograms and Discovering Stage 1 Triple-Negative Breast Cancer
For more than three decades, Mitchell cared for others in high-stakes cardiac and radiological environments. Long shifts and competing priorities led her to push back routine mammogram appointments throughout late 2021. When she finally took a day off for her birthday in January 2022, she rescheduled the diagnostic imaging. Dense breast tissue prompted a recommendation for a follow-up appointment, which quickly escalated to a targeted biopsy.
The resulting pathology report revealed triple-negative breast cancer, a clinical classification known for rapid cellular proliferation and a lack of standard hormone receptors. Despite having no family history of the disease and no major identifiable risk factors, Mitchell faced an immediate shift into the patient role. “As a nurse, I knew enough to understand it was serious, but I certainly wasn’t a breast cancer expert,” Mitchell stated. “All of a sudden, I was the patient.”
Balancing Active Chemotherapy While Working at SSM Health
Detection at Stage 1 allowed for prompt clinical intervention. In February 2022, Mitchell initiated a rigorous chemotherapy regimen. The pharmacological side effects included alopecia (hair loss) and chemotherapy-induced peripheral neuropathy, a condition characterized by nerve damage causing numbness or weakness in the hands and feet.
Throughout the treatment window, Mitchell continued working alongside her colleagues at SSM Health St. Joseph Hospital – St. Charles. Flexible institutional support allowed her to manage severe fatigue and adverse symptoms by adjusting her schedule without abandoning her professional responsibilities. Following the conclusion of her systemic therapy, she underwent surgical resection and reconstructive procedures in August 2022. Today, she maintains regular follow-up evaluations and remains cancer-free.
Contraindications & When to Consult a Doctor
Patients with dense breast tissue or a personal history of suspicious clinical findings should consult a qualified physician regarding supplemental screening options beyond standard mammography. Individuals undergoing chemotherapy or targeted cancer treatments must immediately report systemic complications—such as persistent fevers, acute neuropathy, or severe gastrointestinal distress—to their oncology care team. Routine mammography guidelines should be strictly maintained, and any newly discovered palpable lumps, skin dimpling, or nipple retraction warrant prompt diagnostic evaluation regardless of family history.
Mentorship Through Faith Through Fire and Patient Advocacy
The diagnostic ordeal altered Mitchell’s approach to clinical leadership. Navigating unfamiliar medical terminology and therapeutic uncertainty firsthand provided her with a profound appreciation for the psychological burden carried by patients and families. To extend this support beyond the hospital setting, she became a mentor with Faith Through Fire, an organization dedicated to pairing breast cancer survivors with newly diagnosed individuals.
Four years post-diagnosis, Mitchell emphasizes the absolute necessity of maintaining preventive screenings and regular health maintenance. Her trajectory from acute care provider to oncology patient serves as a stark reminder that asymptomatic individuals without family histories remain vulnerable to aggressive malignancies.
References
- American Cancer Society. Breast Cancer Facts & Figures. Atlanta: American Cancer Society, Inc.
- National Cancer Institute. Triple-Negative Breast Cancer Treatment (PDQ®)–Health Professional Version. Bethesda, MD.
- Susan G. Komen Foundation. Understanding Breast Density and Screening Protocols. Dallas, TX.
